Drug Shows Promise Against MS in Mouse Study
Laquinimod seemed to slow progression of the neurological disorder, but human trials neededContinue Reading
Laquinimod seemed to slow progression of the neurological disorder, but human trials neededContinue Reading
Laquinimod seemed to slow progression of the neurological disorder, but human trials neededContinue Reading
In preliminary trial, 4 out of 9 people with acute myeloid leukemia had complete remissionContinue Reading
Rat study suggests PRDM2 helps the brain control impulses to drinkContinue Reading
Mastectomy patients with small tumors, fewer lymph nodes involved, benefit from the therapy, cancer experts agreeContinue Reading
Experts say all recipients should have full-body skin evaluations after transplant surgeryContinue Reading
Changes related to disease found in more than 7,000 genes, though many ‘recover’ five years after quittingContinue Reading
Changes related to disease found in more than 7,000 genes, though many ‘recover’ five years after quittingContinue Reading
Survival rates are all high, but watchful waiting is linked to some cancer spread, British study reportsContinue Reading
Found to protect about 90 percent of adults age 70 and upContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.